Papers
2
Total Citations
21
H-Index
2
About
Dr. Tomokazu Shimizu is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for complex oncologic cases in immunocompromised patients, particularly kidney transplant recipients. His landmark work on robot-assisted radical prostatectomy for localized prostate cancer in Asian renal transplant recipients (17 citations) established critical safety and efficacy benchmarks for this challenging population, demonstrating that robotic surgery can achieve excellent oncologic outcomes without compromising graft function. More recently, Dr. Shimizu’s comparative study on robot-assisted versus open partial nephrectomy for allograft kidney tumors (2025) provides vital evidence supporting robotic approaches for treating de novo renal cell carcinoma in transplanted kidneys—a growing clinical challenge given the 0.2–0.5% malignancy risk in transplant recipients. His work directly addresses the delicate balance between cancer control and graft preservation, offering surgeons standardized protocols for these high-stakes procedures. With cumulative citations reflecting the global relevance of his contributions, Dr. Shimizu continues to shape the frontier of transplant urology, demonstrating that robotic platforms can safely expand treatment options for patients with limited surgical reserve.
Research Focus
Key Achievements
Top Papers
- 1
- 2